Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Maga

Showing results (61-70 of 214) with videos related to

Pageof 22
Sort By:
Nucleic Acids Research|September 19, 2015
The novel influenza A virus protein PA-X and its naturally deleted variant show different enzymatic properties in comparison to the viral endonuclease PALaura Bavagnoli, Stefano Cucuzza, Giulia Campanini, et al.
Antiviral Research|July 21, 2007
NNRTI-selected mutations at codon 190 of human immunodeficiency virus type 1 reverse transcriptase decrease susceptibility to stavudine and zidovudineStefania Paolucci, Fausto Baldanti, Giulia Campanini, et al.
Nature|May 18, 2007
8-oxo-guanine bypass by human DNA polymerases in the presence of auxiliary proteinsGiovanni Maga, Giuseppe Villani, Emmanuele Crespan, et al.
Antiviral Research|March 24, 2010
Slow binding-tight binding interaction between benzimidazol-2-one inhibitors and HIV-1 reverse transcriptase containing the lysine 103 to asparagine mutationAlberta Samuele, Emmanuele Crespan, Samanta Vitellaro, et al.
Chemmedchem|July 20, 2007
N2-benzyloxycarbonylguan-9-yl acetic acid derivatives as HIV-1 reverse transcriptase non-nucleoside inhibitors with decreased loss of potency against common drug-resistance mutationsKassim F Adebambo, Samantha Zanoli, Michael G Thomas, et al.
European Journal of Medicinal Chemistry|May 5, 2009
Determination of permeability and lipophilicity of pyrazolo-pyrimidine tyrosine kinase inhibitors and correlation with biological dataElena Dreassi, Alessandra Tania Zizzari, Federico Falchi, et al.
International Journal of Molecular Sciences|January 28, 2026
Dissecting the Interaction Domains of SARS-CoV-2 Nucleocapsid Protein and Human RNA Helicase DDX3X and Search for Potential InhibitorsCamilla Lodola, Maria Michela Pallotta, Fabrizio Manetti, et al.
Nucleic Acids Research|July 11, 2003
Selective interactions of human kin17 and RPA proteins with chromatin and the nuclear matrix in a DNA damage- and cell cycle-regulated mannerLaurent Miccoli, Denis S F Biard, Isabelle Frouin, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 11, 2004
The human DNA polymerase lambda interacts with PCNA through a domain important for DNA primer binding and the interaction is inhibited by p21/WAF1/CIP1Giovanni Maga, Giuseppina Blanca, Igor Shevelev, et al.
Current Pharmaceutical Design|April 12, 2002
Non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors: past, present, and future perspectivesGiuseppe Campiani, Anna Ramunno, Giovanni Maga, et al.
Pageof 22

Showing results (61-70 of 214) with videos related to

Sort By:
Pageof 22
Nucleic Acids Research|September 19, 2015
The novel influenza A virus protein PA-X and its naturally deleted variant show different enzymatic properties in comparison to the viral endonuclease PALaura Bavagnoli, Stefano Cucuzza, Giulia Campanini, et al.
Antiviral Research|July 21, 2007
NNRTI-selected mutations at codon 190 of human immunodeficiency virus type 1 reverse transcriptase decrease susceptibility to stavudine and zidovudineStefania Paolucci, Fausto Baldanti, Giulia Campanini, et al.
Nature|May 18, 2007
8-oxo-guanine bypass by human DNA polymerases in the presence of auxiliary proteinsGiovanni Maga, Giuseppe Villani, Emmanuele Crespan, et al.
Antiviral Research|March 24, 2010
Slow binding-tight binding interaction between benzimidazol-2-one inhibitors and HIV-1 reverse transcriptase containing the lysine 103 to asparagine mutationAlberta Samuele, Emmanuele Crespan, Samanta Vitellaro, et al.
Chemmedchem|July 20, 2007
N2-benzyloxycarbonylguan-9-yl acetic acid derivatives as HIV-1 reverse transcriptase non-nucleoside inhibitors with decreased loss of potency against common drug-resistance mutationsKassim F Adebambo, Samantha Zanoli, Michael G Thomas, et al.
European Journal of Medicinal Chemistry|May 5, 2009
Determination of permeability and lipophilicity of pyrazolo-pyrimidine tyrosine kinase inhibitors and correlation with biological dataElena Dreassi, Alessandra Tania Zizzari, Federico Falchi, et al.
International Journal of Molecular Sciences|January 28, 2026
Dissecting the Interaction Domains of SARS-CoV-2 Nucleocapsid Protein and Human RNA Helicase DDX3X and Search for Potential InhibitorsCamilla Lodola, Maria Michela Pallotta, Fabrizio Manetti, et al.
Nucleic Acids Research|July 11, 2003
Selective interactions of human kin17 and RPA proteins with chromatin and the nuclear matrix in a DNA damage- and cell cycle-regulated mannerLaurent Miccoli, Denis S F Biard, Isabelle Frouin, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 11, 2004
The human DNA polymerase lambda interacts with PCNA through a domain important for DNA primer binding and the interaction is inhibited by p21/WAF1/CIP1Giovanni Maga, Giuseppina Blanca, Igor Shevelev, et al.
Current Pharmaceutical Design|April 12, 2002
Non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors: past, present, and future perspectivesGiuseppe Campiani, Anna Ramunno, Giovanni Maga, et al.
Pageof 22